JP Morgan Chase & Co’s Rigel Pharmaceuticals RIGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $990K | Buy |
|
|||||
|
2025
Q2 | $186K | Sell |
|
|||||
|
2025
Q1 | $997K | Sell |
|
|||||
|
2024
Q4 | $3.04M | Buy |
|
|||||
|
2024
Q3 | $425K | Buy |
|
|||||
|
2024
Q2 | $149K | Buy |
|
|||||
|
2024
Q1 | $152K | Sell |
|
|||||
|
2023
Q4 | $186K | Sell |
|
|||||
|
2023
Q3 | $231K | Sell |
|
|||||
|
2023
Q2 | $350K | Sell |
|
|||||
|
2023
Q1 | $690K | Buy |
|
|||||
|
2022
Q4 | $258K | Buy |
|
|||||
|
2022
Q3 | $152K | Buy |
|
|||||
|
2022
Q2 | $107K | Sell |
|
|||||
|
2022
Q1 | $284K | Buy |
|
|||||
|
2021
Q4 | $201K | Sell |
|
|||||
|
2021
Q3 | $276K | Buy |
|
|||||
|
2021
Q2 | $323K | Buy |
|
|||||
|
2021
Q1 | $219K | Sell |
|
|||||
|
2020
Q4 | $2.03M | Buy |
|
|||||
|
2020
Q3 | $145K | Sell |
|
|||||
|
2020
Q2 | $740K | Sell |
|
|||||
|
2020
Q1 | $990K | Buy |
|
|||||
|
2019
Q4 | $397K | Buy |
|
|||||
|
2019
Q3 | $103K | Sell |
|
|||||
|
2019
Q2 | $1.45M | Buy |
|
|||||
|
2019
Q1 | $105K | Sell |
|
|||||
|
2018
Q4 | $99K | Sell |
|
|||||
|
2018
Q3 | $435K | Sell |
|
|||||
|
2018
Q2 | $3.99M | Sell |
|
|||||
|
2018
Q1 | $7.16M | Buy |
|
|||||
|
2017
Q4 | $5.31M | Sell |
|
|||||
|
2017
Q3 | $3.25M | Sell |
|
|||||
|
2017
Q2 | $3.99M | Buy |
|
|||||
|
2017
Q1 | $4.8M | Sell |
|
|||||
|
2016
Q4 | $4.25M | Sell |
|
|||||
|
2016
Q3 | $7.94M | Buy |
|
|||||
|
2016
Q2 | $3.54M | Buy |
|
|||||
|
2014
Q1 | – | Sell |
|
|||||
|
2013
Q4 | $31K | Sell |
|
|||||
|
2013
Q3 | $327K | Buy |
|
|||||
|
2013
Q2 | $213K | Buy |
|